LABORATORY-BASED MEDICAL ONCOLOGY PRACTICE
We are very different from other personalized medicine profiling labs. That’s because we are not a big laboratory company. We are a private medical practice - a laboratory-based medical practice, founded by Dr. Weisenthal in 1992 after he had worked as a medical oncologist and cancer researcher at the National Cancer Institute, for the Veterans Administration, and at national cancer testing laboratory, where he was Medical Director. We do not have investors, partners, or shareholders.
Larry Weisenthal, M.D.,Ph.D. is a medical doctor. He is board certified in Medical Oncology and Internal Medicine. Dr. Weisenthal received his post-doctoral oncology training at the National Cancer Institute, where he was Clinical Associate, cancer researcher, and Lt. Commander in the U.S. National Health Service. He also holds a separate Ph.D. degree in pharmacology.
Dr. Weisenthal is regarded by many experts in the field of cytometric profiling as the world’s leading authority. An early pioneer and sustaining force, Dr. Weisenthal invented the cytometric profiling technology experts have called the “gold standard.” In addition, he originated and was an early champion of the “cell death” assay endpoint, which eclipsed less accurate methods and is now recognized worldwide as the technology standard.
A SMALL STAFF FOCUSING ON ONE PATIENT AT A TIME
We have a very small laboratory staff consisting of medical technologists and laboratory technicians. They are dedicated, skilled, and highly experienced at assisting Dr. Weisenthal in performing cytometric profiling for cancer patients.
Our administrative staff is also small, consisting of a medical finance specialist and two patient support specialists. As is the case with our laboratory staff, all are highly experienced and have worked with Dr. Weisenthal for many years.
Having a small staff allows us to work closely together as a team in order to afford each patient a highly-focused, highly-caring, and highly-personalized experience.
We invest a great deal of time and effort in performing a thorough, accurate, high quality analysis for each patient. We leave high volume batch-testing, economies of scale, investor influences, and corporate cost-cutting measures to others.
We have neither the need nor the desire to grow into a large laboratory company - many of us have worked in that environment before. Our goal is to help one patient at a time. In this, we spare no effort or expense. We apply three to five separate testing technologies for each patient and spend hours in sample preparation to achieve the best result. When it comes to your care there is no such thing as “good enough.”
Each of us at Weisenthal Cancer Group is closely involved at some level in every patient’s personalized cytometric profiling service. We are all highly dedicated. We understand that what happens in our laboratory - and literally in our own hands - is each patient’s very best hope of receiving the chemotherapy treatment that will extend his or her life. We take that enormous responsibility very seriously and very personally.
FULLY LICENSED AND ACCREDITED
Weisenthal Cancer Group is licensed by the United States Department of Health and Human Services and by the State of California. This approval allows us to perform testing for patients in the United States and throughout the world.
U.S. CLIA accreditation and California license numbers are show below:
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CLIA License Number: 05D0662326
STATE OF CALIFORNIA
CA License Number: 203076